Skip to main content
. 2021 Sep 14;12(19):1878–1885. doi: 10.18632/oncotarget.28054

Table 1. Characterization of nanoTCEs1.

Formulation Diameter (nm) PDI2 Zeta Potential (mV)
Isotype/CD3 140.5 ± 1.0 0.11 ± 0.02 0.9 ± 0.2
CD33/CD3 141.3 ± 1.0 0.07 ± 0.01 1.1 ± 0.1

1Mean ± standard deviation; 2polydispersity index (PDI).